Health Care Select Sector SPDR Fund (XLV)
| Assets | $38.48B |
| Expense Ratio | 0.09% |
| PE Ratio | 24.21 |
| Shares Out | 271.17M |
| Dividend (ttm) | $2.27 |
| Dividend Yield | 1.59% |
| Ex-Dividend Date | Sep 23, 2024 |
| Payout Ratio | 38.49% |
| 1-Year Return | +11.41% |
| Volume | 9,323,104 |
| Open | 141.51 |
| Previous Close | 141.21 |
| Day's Range | 141.30 - 143.08 |
| 52-Week Low | 129.33 |
| 52-Week High | 159.64 |
| Beta | 0.69 |
| Holdings | 63 |
| Inception Date | Dec 16, 1998 |
About XLV
Fund Home PageThe Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund tracks health care stocks from within the S&P 500 Index, weighted by market cap. XLV was launched on Dec 16, 1998 and is issued by State Street.
Top 10 Holdings
55.96% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.03% |
| UnitedHealth Group Incorporated | UNH | 10.47% |
| Johnson & Johnson | JNJ | 7.16% |
| AbbVie Inc. | ABBV | 5.65% |
| Merck & Co., Inc. | MRK | 4.71% |
| Abbott Laboratories | ABT | 3.93% |
| Thermo Fisher Scientific Inc. | TMO | 3.68% |
| Intuitive Surgical, Inc. | ISRG | 3.62% |
| Amgen Inc. | AMGN | 2.88% |
| Danaher Corporation | DHR | 2.84% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 23, 2024 | $0.577 | Sep 25, 2024 |
| Jun 24, 2024 | $0.573 | Jun 26, 2024 |
| Mar 18, 2024 | $0.523 | Mar 21, 2024 |
| Dec 18, 2023 | $0.598 | Dec 21, 2023 |
| Sep 18, 2023 | $0.540 | Sep 21, 2023 |
| Jun 20, 2023 | $0.542 | Jun 23, 2023 |
News
XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)
The healthcare sector, including the SPDRs Select Health Care ETF, faces high uncertainty due to political factors and elevated valuations, prompting a downgrade from hold to sell. My investment appro...
RFK Jr.'s HHS nomination sparks concern over pharma stocks
President-elect Trump's decision to nominate Robert F. Kennedy Jr. as the Secretary of Health and Human Services (HHS) has sparked concerns, particularly about his skepticism toward the pharmaceutical...
Jim Cramer on why RFK Jr. could upend HHS
Mad Money' host Jim Cramer explains why vaccine skeptic Robert F. Kennedy Jr. could upend the Department of Health and Human Services if he leads it.
5 Healthcare Stocks to Buy in a Beaten-Up Sector
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity.
Regulatory outlook is hazy for health care under Trump admin, says former Thomson Reuters CEO
Thomas Glocer, former Thomson Reuters CEO, joins 'Squawk on the Street' to discuss how policy is expected in the health care sector, how discussions are going regarding M&A, and much more.
Why most healthcare stocks are falling with Trump's win, with some exceptions
Investors are worried about what a Trump administration means for hospital operators and vaccine makers, but are optimistic about the fate of Medicare Advantage plan providers.
Trump Will Create New Winners and Losers in Healthcare
Market reactions sharply diverged among healthcare companies as investors expect changes to Obamacare, Medicare.
Breaking Down S&P 500 Returns by Sector Since 2020 Election
The S&P 500 Index has returned nearly 81% since the last presidential election, with a wide disparity between sector performance. The S&P 500's gains since Nov. 3, 2020 reflect an annual return of nea...
XLV: Here Is A Good Risk-Return Ratio
The healthcare sector shows resilience and strong earnings growth prospects for Q3 and Q4. The entire US market is expensive, driven by peak company margins. Healthcare sector showed strong returns du...
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.
XLV ETF: Time To Start A DCA In Healthcare Sector
I have decided to continue my Dollar Cost Averaging, or DCA, strategy in the healthcare sector through The Health Care Select Sector SPDR® Fund ETF. The XLV ETF offers a low expense ratio of 0.09%, a ...
Final Trades: Nvidia, Health Care Select Sector SPDR and Samsara
The Investment Committee give you their top stocks to watch.
Final Trades: Palo Alto Networks, Delta Air Lines, PayPal and the XLV
The Investment Committee give you their top stocks to watch for the second half.
XLV: Healthcare Outperforming In The Second Half, Bullish Tailwinds Persist
I am bullish on the Health Care Select Sector SPDR ETF (XLV) due to its attractive valuation, strong technical setup, and favorable seasonality heading into Q4. Eli Lilly (LLY) is a standout component...
Healthcare Stocks Have Popped. Consider These 2 That Haven't.
Money has poured into the sector as markets have grown concerned about the economy.
Charting the next health care stocks to break out
Chris Verrone, Strategas head of technical and macro research, joins 'Fast Money' to give his health care playbook.
The Highest Quality Dividend-Growth Healthcare Stocks
Quality Snapshots evaluate dividend-growth companies based on five quality factors including financial performance, resilience and dividend safety. This healthcare sector overview identifies 26 top qu...
Healthcare Stocks Are Closing the Gap. Here Are the Latest Winners.
After trailing the broader market, this week's selloff has allowed healthcare stocks to nearly catch up.
Stock Of The Day: XLV Shatters Resistance Barrier, Establishes New Support Level
The chart of the Health Care Select Sector SPDR Fund XLV offers two valuable technical analysis lessons.
XLV: A Strong Way To Benefit From An Aging And Unhealthy Population
Demand for Health Care services is inelastic and expected to grow due to aging population and economic slowdown. XLV ETF provides cheap investment in healthcare companies across various sub-sectors li...
Final Trades: Qualcomm, Apple, Adobe and the XLV
The Investment Committee gives you their top stocks to watch for the second half.
Final Trades: Leidos, Oracle, Cheniere Energy and the XLV
The Investment Committee share their top plays for the second half.
CEF Report | May 2024 | Activism Is Heating Up
Taxable bond CEF space value shrinking as discounts tighten. Opportunities exist, especially following activists. Focus on top-down assessment, cheap sectors, and specific funds like Cohen & Steers Se...
XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff
The healthcare sector is one that exhibits "inelastic demand" and has the unique advantage of being essential to peoples' lives. Healthcare's valuation has been stunted by risks such as the "patent cl...